Related Experiment Video
Updated: Oct 21, 2025

Investigating von Willebrand Factor Pathophysiology Using a Flow Chamber Model of von Willebrand Factor-platelet String Formation
Published on: August 14, 2017
Type 2N VWD: Conclusions from the Spanish PCM-EVW-ES project
Almudena Pérez-Rodríguez1, Javier Batlle1, Joana Costa Pinto1
1Complexo Hospitalario Universitario A Coruña, INIBIC, A Coruña, Spain.
Type 2N von Willebrand disease (VWD) diagnosis requires careful evaluation to distinguish it from mild hemophilia A. Next-generation sequencing offers a cost-effective and accurate first-line diagnostic approach for this condition.
Area of Science:
- Hematology
- Genetics
- Molecular Biology
Background:
- Type 2N von Willebrand disease (VWD) is characterized by reduced binding of von Willebrand factor (VWF) to factor VIII (FVIII).
- This abnormal binding leads to low FVIII levels, potentially causing misdiagnosis as mild hemophilia A.
- Accurate diagnosis is crucial for appropriate genetic counseling and treatment.
Purpose of the Study:
- To identify diagnostic and therapeutic challenges in type 2N VWD.
- To provide detailed descriptions of identified phenotypes and mutations.
Main Methods:
- Genetic analysis, including next-generation sequencing.
- In vitro assays to measure VWF:FVIIIB activity.
Main Results:
- Three type 2N mutations (p.Arg816Trp, p.Arg854Gln, p.Arg763Ser) were identified in 28 patients, with two being globally frequent.
- The observed mutational spectrum differs from that in neighboring regions.
- Clinical and laboratory data alone could misclassify asymptomatic carriers and severe phenotype patients.
Conclusions:
- Next-generation sequencing demonstrates high detection rates and affordability.
- This technology is recommended as a primary diagnostic tool for type 2N VWD.
Related Concept Videos
Peripheral Arterial Disease II: Clinical Manifestations and Diagnostic Evaluation
Blood Typing
Antigens are protein molecules that reside on the surface of red blood cells (RBCs). The ABO and Rh blood typing systems target...
Mitral Stenosis II: Clinical features and Diagnostic Tests
Varicose Veins II: Diagnostic Studies and Interprofessional Care
Venous Thrombosis II: Clinical Manifestations and Diagnostic Studies
Esophageal Varices-II: Clinical Features and Management
In the initial assessment, a thorough review of the patient's medical history is vital to identify risk factors such as liver disease, alcohol...

